JoVE Journal
Medicine
Medicine
This Contenuto is Open Access.
Capitoli
Riepilogo
A novel methodology that is employed for the treatment of recurrent glioblastomas is described. This treatment approach employs the application of alternating electric tumor treating fields (TTFields), known as TTF Therapy in combination with bevacizumab, a targeted agent that is currently FDA approved as monotherapy.